Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A Meeting Abstract
| Authors: | Sakai, H.; Morise, M.; Felip, E.; Veillon, R.; Garassino, M. C.; Raskin, J.; Viteri, S.; Mazieres, J.; Cortot, A. B.; Smit, E.; Thomas, M.; Cho, B. C.; Conte, P.; Yang, J. C. H.; Chen, Y. M.; Park, K.; Gottfried, M.; Britschgi, C.; Le, X.; Paik, P. |
| Abstract Title: | Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A |
| Meeting Title: | 2021 Annual Meeting of the Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2021 Feb 18-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S290 |
| Language: | English |
| ACCESSION: | WOS:000683609100127 |
| DOI: | 10.1016/j.annonc.2021.05.540 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O13-3 -- Source: Wos |
